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continuing to the equilibrium phase. T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced image revealed a high intensity effect at the early phase that continued to the next phase. On the other hand, it contained a low intensity area by a fat suppression of that image. In addition, a T2-weighted image did not show a high intensity effect. Laparotomy was performed on the second day of hospitalization. The tumor had arisen from the ligamentum teres of the liver, and no metastasis or invasion of other organs was noted. It consisted of a lipid component of mature adipocytes and a fibrous component of deep dyeing pleomorphic or multinuclear atypical stromal cells. Immunohistochemical study of the atypical stromal cells demonstrated that they were positive for MDM2 and CDK4. A pathological diagnosis of atypical lipomatous tumor (ALT) was made, and the patient was discharged on the eighth day following the procedure. At the 6-mo follow-up dynamic CT, the patient was free of recurrence or metastasis. We experienced a patient with ALT in the ligamentum teres of the liver. This case suggests the need for a careful and detailed examination when encountering patients presenting with a mass; when neoplastic lesion is confirmed by image inspection, we should thoroughly investigate, including further image investigations and pathologic examination. The latter is the most important. 
INTRODUCTION
Liposarcoma is one of the most common adult soft tis sue sarcomas, accounting for approximately 20% of all mesenchymal malignancies [13] . Welldifferentiated and dedifferentiated liposarcoma, especially the former is Usuda D et al . Atypical lipomatous tumor in the ligamentum teres of liver called atypical lipomatous tumor (ALT). It is the most common intraabdominal primary sarcoma [4] . On the other hand, it is an extremely rare malignant adipose mesenchymal tumor [5] . Typically, it is locally aggressive and shows a tendency toward recurrence after surgical excision, despite the fact that it does not metastasize and very rarely dedifferentiates [2] . As far as we know, there have been no reported liposarcoma cases occu rring from the ligamentum teres of the liver. Herein, we report a case with a review of the existing literature.
CASE REPORT
The patient was a 61yearold male, referred to our hospital with a threemonth history of persistent epi gastralgia and right hypochondralgia. Patient medical history included transient ischemic attacks, hypertension and hyperlipidemia, for which he was being treated with aspirin, antihypertensive medication, and bezafibrate. He was diagnosed with hepatic hemangioma follow ing complete medical checkup ten years prior to his visit to our hospital. Examination revealed a fistsized mass at the epigastric fossa. Other findings were nor mal. Routine blood tests showed elevated lowdensity lipoprotein cholesterol, decreased creatine kinase, and abnormal glucose tolerance. Blood count, Creactive protein, liver enzyme, tumor maker including carcinoe mbryonic antigen, carbohydrate antigen 199, a fetal specific glycoprotein antigen, and soluble interleukin-2 receptor were all within normal limits. In addition, the patient was negative for hepatitis B, C and syphilis, as well as collagen diseases. Abdominal ultrasonography (GE Healthcare, LOGIQ E9 XDclear 2.0) showed two tumors located in the right posterior superior seg ment of liver and ventromedian. The former showed hyperechoic lesion, namely hemangioma, the latter showed mosaic echoic lesion with poor blood flow signal, as well as linear hyperechoic part inside and a clear border to the surroundings (Figure 1 ). Dynamic CT (GE Healthcare, Discovery CT750 HD) revealed a highly enhanced effect from the portalvenous phase, continuing to the equilibrium phase for the latter tu mor. MRI (GE Haelthcare, Signa HDxt 1.5T), including fat suppression radiography to confirm the existence of a lipid component, was performed. T1weighted ga doliniumethoxybenzyldiethylenetriamine pentaacetic acidenhanced imaging revealed a high intensity effect at the early phase that continued to the next phase. In addition, it showed a partial low intensity area by a fat suppression image (yellow arrow). On the other hand, a T2weighted image did not show a highly enhanced effect ( Figure 2 ). Absence of metastasis was confir med. Gallium67 scintigraphy (Canon Medical Systems, E.CAM) showed that there was no abnormal accumu lation to the abdominal tumor.
The above findings prompted a diagnosis of abdominal mesenchymoma, and we admitted the patient to the hospital. Laparotomy was performed on the second day postadmission. During an operation, we paid attention to two points for completing the tumor removal, avoiding bleeding and reducing the risk of recurrence; one was to apply gauze for discriminating between the tumor and surrounding tissues, and the other was to finely ligate surrounding blood vessels and cut them little by little. Intraoperative findings revealed as follows: (1) the tumor was arisen from the ligamen tum teres of the liver and was highly covered with a capsule without invasion, adhesion, or infiltration to surrounding tissues. Therefore, it was easily enucleat ed; and (2) the absence of metastasis or other organ invasion was confirmed ( Figure 3A ). In the resected split specimen, the tumor size measured 13 cm x 9 cm x 5 cm and consisted of yellow lipid and a white fibrous component ( Figure 3B ). The lipid component was composed of mature adipocytes, and deep dyeing pleomorphic or multinuclear atypical stromal cells were confirmed in the fibrous component ( Figure 4A and B) . Immunohistochemistry of atypical stromal cells was po CT reveals high enhanced effect of tumor from portal-venous phase continuing to the equilibrium phase (red arrow). T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced image revealed a high intensity effect at the early phase, which continued to the next phase (red arrow). In addition, it showed a partial low intensity area by a fat suppression image (yellow arrow). On the other hand, the T2-weighted image did not show a high intensity effect. Gd: Gadolinium; EOB: Ethoxybenzyl; DTPA: Diethylenetriamine pentaacetic acid-enhanced; FS: Fat suppression.
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Usuda D et al . Atypical lipomatous tumor in the ligamentum teres of liver sitive for MDM2 and CDK4 and negative for αSMA, S100 protein, CD34 and STAT6 ( Figure 4C and D) . Based on these findings, a pathological diagnosis of atypical lipomatous tumor (ALT) was made. The pati ent responded well and was discharged on the eighth day postprocedure. At the 6mo followup dynamic CT appointment, the patient was free of recurrence or metastasis.
DISCUSSION
This is the first case of liposarcoma occurring from the ligamentum teres of the liver. As laid out in the World Health Organization's classification of tumors of soft tissue and bone: IARC Press 2013, liposarcomas are divided into five subtypes: myxoid, pleomorphic, dedifferentiated, mixed liposarcoma, and ALT [5] . ALT is an intermediate tumor with risk of local recurrence but no potential for metastasis [1, 5, 6] . The points of differential diagnosis are focused on those mentioned above, espe cially dedifferentiated liposarcoma. However, it can be difficult to distinguish ALT from poorly differentiated sarcomas and benign adipose tumors [7] . The clinical pr esentation of ALT tends to be a progressive mass that can cause symptoms that are aesthetic, functional, or compressive in nature, depending on its size and localization [2] . On the other hand, chromosomal translocations and fusion genes are very commonly found in human cancer, particularly in liposarcoma and other subtypes of sarcomas [8] . The advancement of nextgeneration sequencing technologies, such as whole genome se quencing, has made it possible to discover novel chro mosomal translocations and fusion genes in different tumors [8] . Recently, these nextgeneration sequencing approaches have led to the identification of many novel chromosomal translocations and gene fusions in different types of sarcomas [8] . In addition to sarcoma fusion genes that had previously been discovered, these novel specific fusion genes and their associated molecular events represent important targets for novel therapeutic approaches to sarcoma treatment [8] . Of these, the majority of ALTs express MDM2 (97%) and CDK4 (92%) on chromosome 12q1315, compared to benign adipose tumors (MDM2, 5%; CDK4, 2%) [7, 9] . The sensitivity and specificity of MDM2 and CDK4 immunostainings used to identify ALT among other soft tissue tumors were 97% and 92%, and 83% and 95%, respectively [7] . Therefore, MDM2 and CDK4 immunostaining is especially useful in separating ALT from large groups of differentiated adipose tumors, and this is important for the differential diagnosis [7] . In this case, we finally diagnosed ALT based on the immunostaining findings, which were positive for MDM2 and CDK4. In addition, there were also caveolae, which are cholesterolenriched invaginations of the plasma membrane that are involved in various processes, in cluding the absorption of glucose and fatty acids, cell transduction, and mechanoprotection [10] . In vitro analy sis shows that both the biogenesis and the function of caveolae are dependent on the activity of the Caveo lin (Cav1, 2 and 3) and Cavin (Cavin1, 2, 3 and 4) protein families [10] . Cavin2, along with Cavin1, Cav1, and Cav2, is mainly expressed in ALT, while it is almost impossible to detect in the more aggressive myxoid, pleomorphic tumors, and ALT [10] . In addition, the expression of Cavin2 increases in liposarcoma tu mor cell lines during differentiation, as opposed to pro liferation in immunoblotting and immunofluorescence analysis [10] . Therefore, Cavin2 serves as a useful marker that can be used to discriminate the degree of differen tiation in liposarcoma tumors [10] . More studies are still necessary to determine the treatment and therapeutic strategies needed to im prove the survival rate of patients with liposarcoma, as the disease is generally associated with frequent relapse [11] . To date, surgical resection has been the ma instay of curative treatment [11] . Several authors have recommended using wide excision with free margins in order to minimize the risk of recurrence, while others have reported having good results and a low rate of recurrence when opting for more conservative or even marginal excision, thereby avoiding complications caused by surgical site morbidity [2] . In fact, marginal excision is a good alternative in cases where the tumor is located near vascular or nerve structures, and it is not associated with elevated recurrence [2] . For metastatic disease, syste mic treatment options have historically been represented by standard cytotoxic chemotherapy [3] . Eribulin has rec ently been approved for advanced liposarcoma, after anthracyclinecontaining regimen demonstrated an overall survival advantage in liposarcoma in a randomiz ed Phase Ⅲ clinical trial. However, further studies are required to better understand the precise mechanism of action of this agent and its potential role in combina tion schedules [12] . On the other hand, recent innovative therapies have been introduced and are currently part of the therapeutic armamentarium positively impacting disease control and patient quality of life [3] . Moreover, a better understanding of the molecular characteristics of each soft tissue sarcoma subtype over the last decade has allowed the detection of new potential targets and the development of novel, biologydriven compounds at different stages of testing [3] . Peculiar molecular featu res and fundamental signaling pathways now represent druggable targets for novel therapies [3] . Therapy that combines both CDK4 and RTK inhibitors may prove to be an effective option for ALT patients with RTK gene amplification [9] . In addition, liposarcoma subsets are less mutated, but they do express immunogenic self antigens; as a result, strategies to improve antigen pre sentation and T-cell infiltration may potentially allow for successful immunotherapy in patients who have been given these diagnoses [13] . Long survival is correlated with the active resection of recurrence and recognition of highgrade dedifferenti ated type liposarcoma at an early stage [10, 11] . In addition, according to recent basic research, although limited co mpared to other malignancies, formalinfixed paraffin embedded tissue biomarkers, namely microRNA155, may be novel independent indicators of unfavorable prognosis in liposarcoma [14] . However, there remains a need to identify predictive biomarkers for the better se lection of target population and testing of combinations of drugs with the ultimate goal of improving outcomes [3] .
In conclusion, we experienced a patient with ALT occurring in the ligamentum teres of the liver. This case suggests the need for a careful and detailed examinati on when encountering patients presenting with a mass; when neoplastic lesion is confirmed by image inspec tion, we should thoroughly investigate, including further image investigations and pathologic examination. The latter is especially important.
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Case characteristics
A three-month history of persistent epigastralgia and right hypochondralgia.
Clinical diagnosis
Abdominal tumor. 
ARTICLE HIGHLIGHTS
Laboratory diagnosis
Routine blood tests showed elevated low-density lipoprotein cholesterol, decreased creatine kinase, and abnormal glucose tolerance.
Imaging diagnosis
Abdominal mesenchymoma based on MRI, including of fat suppression radiography.
Pathological diagnosis
Immunohistochemical study of atypical stromal cells, namely tumor cells were positive for MDM2 and CDK4 and negative for α-SMA, S-100 protein, CD34 and STAT-6, which led to the pathological diagnosis of atypical lipomatous tumor (ALT).
Treatment
Surgery.
Related reports
ALT is an intermediate tumor with risk of local recurrence but no potential for metastasis. However, ALT may be difficult to distinguish from benign adipose tumors and poorly differentiated sarcomas. Up to now, MDM2 and CDK4 immunostaining have been particularly useful in separating ALT from the large group of differentiated adipose tumors, and they are important for the differential diagnosis. To date, surgical resection has been the mainstay of curative treatment. Long survival is correlated with the active resection of recurrence and recognition of high-grade dedifferentiated type liposarcoma at an early stage. As far as we know, there have been no reported ALT cases occurring from the ligamentum teres of the liver.
Term explanation
ALT: Atypical lipomatous tumor.
Experiences and lessons
When neoplastic lesion is confirmed by image inspection, we should thoroughly investigate, including further image investigations and pathologic examination. The latter is especially important.
